NO960684D0 - Monoklonalt antistoff som induserer apoptose - Google Patents

Monoklonalt antistoff som induserer apoptose

Info

Publication number
NO960684D0
NO960684D0 NO960684A NO960684A NO960684D0 NO 960684 D0 NO960684 D0 NO 960684D0 NO 960684 A NO960684 A NO 960684A NO 960684 A NO960684 A NO 960684A NO 960684 D0 NO960684 D0 NO 960684D0
Authority
NO
Norway
Prior art keywords
antibody
monoclonal antibody
induces apoptosis
myelocytic
cell
Prior art date
Application number
NO960684A
Other languages
English (en)
Norwegian (no)
Other versions
NO960684L (no
Inventor
Naoshi Fukushima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO960684L publication Critical patent/NO960684L/no
Publication of NO960684D0 publication Critical patent/NO960684D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO960684A 1993-09-03 1996-02-21 Monoklonalt antistoff som induserer apoptose NO960684D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP05242110 1993-09-03
PCT/JP1994/001453 WO1995006748A1 (fr) 1993-09-03 1994-09-02 Anticorps monoclonal permettant d'induire une apoptose

Publications (2)

Publication Number Publication Date
NO960684L NO960684L (no) 1996-02-21
NO960684D0 true NO960684D0 (no) 1996-02-21

Family

ID=17084452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960684A NO960684D0 (no) 1993-09-03 1996-02-21 Monoklonalt antistoff som induserer apoptose

Country Status (19)

Country Link
US (4) US5840344A (sv)
EP (1) EP0721015B1 (sv)
KR (1) KR100241863B1 (sv)
CN (1) CN1046314C (sv)
AT (1) ATE280835T1 (sv)
AU (1) AU692466B2 (sv)
CA (1) CA2169950A1 (sv)
CZ (1) CZ294359B6 (sv)
DE (1) DE69434097T2 (sv)
FI (1) FI960567A (sv)
HU (1) HU222989B1 (sv)
NO (1) NO960684D0 (sv)
PL (1) PL181783B1 (sv)
RU (1) RU2202615C2 (sv)
SK (1) SK281964B6 (sv)
TW (1) TW426687B (sv)
UA (1) UA50708C2 (sv)
WO (1) WO1995006748A1 (sv)
ZA (1) ZA946767B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100241863B1 (ko) * 1993-09-03 2000-03-02 나가야마 오사무 아포토시스를 야기시키는 모노클론성항체
US6579692B1 (en) 1996-03-06 2003-06-17 Chugai Seiyaku Kabushiki Kaisha Method of screening apoptosis inducing substances
EP0935001B2 (en) 1996-07-15 2011-08-10 Chugai Seiyaku Kabushiki Kaisha Novel vegf-like factors
US7531643B2 (en) 1997-09-11 2009-05-12 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
CA2303072A1 (en) * 1997-09-11 1999-03-18 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
US7696325B2 (en) 1999-03-10 2010-04-13 Chugai Seiyaku Kabushiki Kaisha Polypeptide inducing apoptosis
WO2000053634A1 (fr) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Fv monocatenaire induisant l'apoptose
US20040058393A1 (en) * 2000-04-17 2004-03-25 Naoshi Fukishima Agonist antibodies
RU2408606C2 (ru) 2000-10-20 2011-01-10 Тугаи Сейяку Кабусики Кайся Соединение - агонист тро
JP4261907B2 (ja) * 2000-10-20 2009-05-13 中外製薬株式会社 低分子化アゴニスト抗体
US7195771B1 (en) 2000-11-21 2007-03-27 Kimberly-Clark Worldwide, Inc. Water-soluble lotions for paper products
AU2002361642A1 (en) * 2001-11-16 2003-06-10 The University Of Tennessee Research Corporation Recombinant antibody fusion proteins and methods for detection of apoptotic cells
WO2004033499A1 (ja) 2002-10-11 2004-04-22 Chugai Seiyaku Kabushiki Kaisha 細胞死誘導剤
JP2004279086A (ja) 2003-03-13 2004-10-07 Konica Minolta Holdings Inc 放射線画像変換パネル及び放射線画像変換パネルの製造方法
EP1609803A4 (en) * 2003-03-31 2006-05-24 Chugai Pharmaceutical Co Ltd MODIFIED ANTIBODY AGAINST CD22 AND ITS USE
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
US20070281327A1 (en) * 2003-12-12 2007-12-06 Kiyotaka Nakano Methods of Screening for Modified Antibodies With Agonistic Activities
TW200530266A (en) * 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Method of reinforcing antibody activity
EP1712565A4 (en) * 2003-12-12 2009-03-11 Chugai Pharmaceutical Co Ltd AGENTS INDUCING CELL DEATH
US9493569B2 (en) 2005-03-31 2016-11-15 Chugai Seiyaku Kabushiki Kaisha Structural isomers of sc(Fv)2
EP1927367A4 (en) * 2005-05-18 2009-08-12 Univ Tokushima NOVEL PHARMACEUTICAL AGENT BASED ON AN ANTI-HLA ANTIBODY
CA2610987C (en) 2005-06-10 2013-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
WO2007100892A2 (en) * 2006-02-28 2007-09-07 The Board Of Trustees Of The Leland Stanford Junior University Trojan horse immunotherapy
JPWO2008007755A1 (ja) * 2006-07-13 2009-12-10 中外製薬株式会社 細胞死誘導剤
CL2008000719A1 (es) * 2007-03-12 2008-09-05 Univ Tokushima Chugai Seiyaku Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
EP3227436A4 (en) 2014-12-05 2018-06-20 Memorial Sloan Kettering Cancer Center Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
IL259747B (en) 2015-12-04 2022-09-01 Memorial Sloan Kettering Cancer Center Antibodies against fcrl5 and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100241863B1 (ko) * 1993-09-03 2000-03-02 나가야마 오사무 아포토시스를 야기시키는 모노클론성항체
US6579692B1 (en) * 1996-03-06 2003-06-17 Chugai Seiyaku Kabushiki Kaisha Method of screening apoptosis inducing substances
CA2303072A1 (en) * 1997-09-11 1999-03-18 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody inducing apoptosis
WO2000053634A1 (fr) * 1999-03-10 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Fv monocatenaire induisant l'apoptose

Also Published As

Publication number Publication date
US20010001712A1 (en) 2001-05-24
RU2202615C2 (ru) 2003-04-20
WO1995006748A1 (fr) 1995-03-09
CN1046314C (zh) 1999-11-10
ATE280835T1 (de) 2004-11-15
NO960684L (no) 1996-02-21
SK25596A3 (en) 1996-10-02
PL313260A1 (en) 1996-06-24
FI960567A0 (sv) 1996-02-07
CZ294359B6 (cs) 2004-12-15
HU222989B1 (hu) 2004-01-28
US6267959B1 (en) 2001-07-31
FI960567A (sv) 1996-02-07
HU9600206D0 (en) 1996-03-28
HUT74594A (en) 1997-01-28
DE69434097T2 (de) 2006-02-02
EP0721015A1 (en) 1996-07-10
CZ61796A3 (en) 1996-06-12
US6759043B2 (en) 2004-07-06
EP0721015A4 (en) 1999-03-31
US20030147894A1 (en) 2003-08-07
UA50708C2 (uk) 2002-11-15
TW426687B (en) 2001-03-21
PL181783B1 (pl) 2001-09-28
DE69434097D1 (de) 2004-12-02
AU692466B2 (en) 1998-06-11
ZA946767B (en) 1995-04-03
EP0721015B1 (en) 2004-10-27
CA2169950A1 (en) 1995-03-09
US5840344A (en) 1998-11-24
AU7546694A (en) 1995-03-22
SK281964B6 (sk) 2001-09-11
CN1130405A (zh) 1996-09-04
KR100241863B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
NO960684D0 (no) Monoklonalt antistoff som induserer apoptose
NO2017040I2 (no) Natalizumab, anti alfa-4 integrin humanisert monoklonalt antistoff - forlenget SPC
DE69321218D1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
NO20001238D0 (no) Monoklonalt antistoff som induserer apoptose
DE69532889D1 (de) Interleukin-5-spezifische rekombinante antikörper
NO944247D0 (no) Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DK0840620T3 (da) IL-8-antagonister til behandling af astma
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
ATE318844T1 (de) Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
NO894555L (no) Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet.
DE69023717D1 (de) Monoklonaler Antikörper.
IT1254315B (it) Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
ATE58173T1 (de) Monoklonale antikoerper und immunisierung damit.
NO960683L (no) Monoklonalt antistoff som gjenkjenner interstitialcelle-overflateantigen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application